Artivion (AORT) Net Equity Issued and Repurchased (2010 - 2026)

Artivion (AORT) posted Net Equity Issued and Repurchased of $1.2 million for Q1 2026, down 63.88% on a QoQ basis from $3.5 million in Q4 2025, and down 70.1% year-over-year from $4.2 million in Q1 2025.

Artivion (AORT) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends

Artivion's Net Equity Issued and Repurchased history runs 17 years deep, the most recent figure standing at $1.2 million for Q1 2026.

  • Quarterly Net Equity Issued and Repurchased fell 70.1% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.1 million (up 58.96% YoY) and the FY2025 annual result came in at $13.1 million, up 128.25% from the prior year.
  • Net Equity Issued and Repurchased was $1.2 million for Q1 2026 at Artivion, down from $3.5 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $5.2 million in Q3 2025 and bottomed at $24000.0 in Q4 2022.
  • A 5-year average of $1.8 million and a median of $1.2 million in 2026 frame the typical range for Net Equity Issued and Repurchased.
  • Annual changes were most pronounced in 2022 — Net Equity Issued and Repurchased sank 89.33% — and 2023, when it surged 1933.33%.
  • Artivion's Net Equity Issued and Repurchased stood at $24000.0 in 2022, then jumped by 1933.33% to $488000.0 in 2023, then decreased by 9.22% to $443000.0 in 2024, then soared by 681.26% to $3.5 million in 2025, then slumped by 63.88% to $1.2 million in 2026.
  • Business Quant data shows AORT's Net Equity Issued and Repurchased at $1.2 million in Q1 2026, $3.5 million in Q4 2025, and $5.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 12.70 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Artivion 1.25 Bn 1.19 Bn 75.45 Mn 1.25 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.25 Mn
Mar 31, 2026 1.25 Mn
Dec 31, 2025 3.46 Mn
Dec 31, 2025 3.46 Mn
Sep 30, 2025 5.15 Mn
Sep 30, 2025 5.15 Mn
Jun 30, 2025 278,000.00
Jun 30, 2025 278,000.00
Mar 31, 2025 4.18 Mn
Mar 31, 2025 4.18 Mn
Dec 31, 2024 443,000.00
Dec 31, 2024 443,000.00
Sep 30, 2024 1.70 Mn
Sep 30, 2024 1.70 Mn
Jun 30, 2024 59,000.00
Jun 30, 2024 59,000.00
Mar 31, 2024 3.53 Mn
Mar 31, 2024 3.53 Mn
Dec 31, 2023 488,000.00
Dec 31, 2023 488,000.00